Xenobiotica · 1993 · 22 citations · 31 references
PharmacyPharmacologyToxicologyDevelopmental ToxicologyMetabolismReproductive ToxicologyCytochrome P450 EnzymesCytochrome P450-mediated MetabolismDevelopmental ToxicityEnzyme InductionPlacental ToxicologyPrenatal ToxicityCytochrome P450 Isoform DifferencesDrug Metabolism In PregnancyLiver Microsomal MetabolismMaternal-fetal ToxicityTransplacental Exposure
1. 3,3',4,4'-Tetrachlorobiphenyl (TCB) induces liver microsomal 7-ethoxyresorufin-O-deethylase (EROD) activity, and this P450 isoform, i.e. CYP 1, is involved in the metabolism of TCB. 2. TCB administered i.p. to pregnant mice (5-25 mg/kg) induced foetal as well as maternal hepatic EROD activity; in all cases the maternal induced activity was higher than the foetal activity. EROD activity of TCB-induced foetuses increased with developmental age, but decreased with the length of time after treatment. 3. Strain differences were seen; in control mice and TCB-treated dams NMRI > C57BL in EROD activity, but in transplacentally TCB-treated foetuses, C57BL > NMRI. EROD activity in non-pregnant control C57BL mice was higher than in pregnant ones, whereas no activity was seen in control foetuses. 4. Results indicate that TCB at a certain dose can induce foetal metabolism, but that earlier observed foetal accumulation at lower TCB doses is probably a consequence of transplacental transport of maternally-produced metabolites.
31
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Journal of the American Medical Association · 1909 · 7.9K citations · Full text
Drug Metabolism and Disposition
Basic & Clinical Pharmacology & Toxicology · 2014 · 2.5K citations
THE JOURNAL OF BIOLOGICAL CHEMISTRY.
JAMA · 1905 · 612 citations · Full text
Medicine, Dermatology, Oncology +6
Masanori Kuratsune, Takesumi Yoshimura, Junichi Matsuzaka et al. · Environmental Health Perspectives · 1972 · 378 citations · Full text
Pharmacy, Dermatology, Toxicology +13